Pharmacokinetics Study for Probucol

• Status: Completed
• Trial end date: 2009-09-01
• Target enrollment: 0
• Participant gender: Male

Summary

To evaluate the safety and pharmacokinetics of probucol by multiple oral administration in healthy male subjects.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Korea Otsuka Pharmaceutical Co., Ltd.
• Treatments: Probucol

Criteria

Inclusion criteria

• Korean

• Male

• Age from 20 to 40 years at time of informed consent

• BMI more than 19.0 and less than 25.0

• Subjects who meet the following criteria at the time of the screening

• Subjects with ECG results without AV block and with both of qTc and QRS width within the standard values

Exclusion criteria

• History or clinical evidence of significant medical history

• Present or previous significant drug allergy to any prescription or OTC medication